Animal cells and systems

  • 제15권2호
  • /
  • Pages.139-146
  • /
  • 2011
  • /
  • 1976-8354(pISSN)
  • /
  • 2151-2485(eISSN)
한국통합생물학회 (The Korean Society for Integrative Biology)
권호 표지
DOI QR코드

DOI QR Code

Effect of secretory leukocyte protease inhibitor on migration and invasion of human KB oral carcinoma cells

  • Wang, Guanlin (Department of Oral Histology & Developmental Biology, School of Dentistry, Chosun University) ;
  • Lim, Do-Seon (Department of Dental Hygiene, Eulji University) ;
  • Choi, Baik-Dong (Department of Oral Histology & Developmental Biology, School of Dentistry, Chosun University) ;
  • Park, Jin-Ju (Department of Oral Histology & Developmental Biology, School of Dentistry, Chosun University) ;
  • Jeong, Soon-Jeong (Department of Oral Histology & Developmental Biology, School of Dentistry, Chosun University) ;
  • Kim, Jin-Soo (Department of Oral & Maxillofacial Radiology, School of Dentistry) ;
  • Kim, Jae-Duk (Department of Oral & Maxillofacial Radiology, School of Dentistry) ;
  • Park, Jung-Su (Department of Dental Hygiene, Seokang University) ;
  • Kim, Eung-Kwon (Department of Dental Hygiene, Suwon Science College) ;
  • Kim, Byung-Hoon (Department of Dental Material, School of Dentistry, Chosun University) ;
  • Ham, Joo-Hyun (Department of Health Management, Hanseo University) ;
  • Jeong, Moon-Jin (Department of Oral Histology & Developmental Biology, School of Dentistry, Chosun University)
  • 투고 : 2010.10.24
  • 심사 : 2011.01.21
  • 발행 : 2011.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Secretory leukocyte protease inhibitor (SLPI) plays an important role in promoting the invasion and metastasis of a range of cancer cells. However, there are no reports of the expression and function of SLPI in oral carcinoma cells. In this study, the oral carcinoma cell line KB was used to determine whether SLPI affects the proliferation, migration and invasion of oral carcinoma cells. RT-PCR and Western blotting revealed high levels of endogenous SLPI expression in KB cells as well as a strong increase in SLPI secretion after wounding compared to immortalized normal oral keratinocytes (INOK). The wound healing assay revealed more migration of KB cells than INOK cells, and the SLPI treatment increased the migration of KB cells. KB cell proliferation was increased significantly by the SLPI protein but decreased by SLPI-siRNA. SLPI strongly increased the migration and invasion of KB cells. On the other hand, SLPI-siRNA decreased the migration and invasion of KB cells. This suggests that SLPI plays an important role in the metastasis of oral carcinoma cells.

키워드

참고문헌

  1. Aarbiou J, Van AS, Stolk J, Sont JK, de Boer WI, Rabe KF, Van Krieken JH, Mauad T, Hiemstra PS. 2004. Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways. Inflamm Res. 53:230-238. https://doi.org/10.1007/s00011-003-1240-x
  2. Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG. 1991. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest. 87:2207-2215. https://doi.org/10.1172/JCI115255
  3. Ameshima S, Ishizaki T, Demura Y, Imamura Y, Miyamori I, Mitsuhashi H. 2000. Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma. Cancer. 89:1448-1456. https://doi.org/10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO;2-Q
  4. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med. 6:1147-1153. https://doi.org/10.1038/80489
  5. Badinga L, Michel FJ, Simmen RC. 1999. Uterine-associated serine protease inhibitors stimulate deoxyribonucleic acid synthesis in porcine endometrial glandular epithelial cells of pregnancy. Biol Reprod. 61:380-387. https://doi.org/10.1095/biolreprod61.2.380
  6. Chambers AF, Groom AC, MacDonald IC. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563-572. https://doi.org/10.1038/nrc865
  7. Choi BD, Jeong SJ, Wang GL, Kim HJ, Kim BO, Hwang HK, Lim DS, Kim SH, Jeong MJ. 2009. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection. J Endod. 35:997-1002. https://doi.org/10.1016/j.joen.2009.04.008
  8. Clow PA, McNally JG. 1999. In vivo observations of myosin II dynamics support a role in rear retraction. Mol Biol Cell. 10:1309-1323. https://doi.org/10.1091/mbc.10.5.1309
  9. Devoogdt N, Hassanzadeh GG, Zhang J, Brys L, De BP, Revets H. 2003. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA. 100:5778-5782. https://doi.org/10.1073/pnas.1037154100
  10. Devoogdt N, Revets H, Ghassabeh GH, De BP. 2004. Secretory leukocyte protease inhibitor in cancer development. Ann N Y Acad Sci. 1028:380-389. https://doi.org/10.1196/annals.1322.044
  11. Devoogdt N, Revets H, Kindt A, Liu YQ, De Baetselier P, Ghassabeh GH. 2006. The tumor-$\delta$ promoting effect of TNF involves the induction of secretory leukocyte protease inhibitor. J Immunol. 177:8046-8052. https://doi.org/10.4049/jimmunol.177.11.8046
  12. Eisenberg SP, Hale KK, Heimdal P, Thompson RC. 1990. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem. 265:7976-7981.
  13. Franken C, Meijer CJ, Dijkman JH. 1989. Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem. 37:493-498. https://doi.org/10.1177/37.4.2926127
  14. Gipson TS, Bless NM, Shanley TP, Crouch LD, Bleavins MR, Younkin EM, Sarma V, Gibbs DF, Tefera W, McConnell PC, Mueller WT, Johnson KJ, Ward PA. 1999. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol. 162:3653-3662.
  15. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. 1996. Antibacterial activity of antileukoprotease. Infect Immun. 64:4520-4524.
  16. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ. 2000. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60:6281-6287.
  17. Jaumann F, Elssner A, Mazur G, Dobmann S, Vogelmeier C. 2000. Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group. Eur Respir J. 15:1052-1057. https://doi.org/10.1034/j.1399-3003.2000.01513.x
  18. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. 1998. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol. 10:667-671. https://doi.org/10.1016/S0955-0674(98)80044-6
  19. Koshikawa N, Nakamura T, Tsuchiya N, Isaji M, Yasumitsu H, Umeda M, Miyazaki K. 1996. Purification and identification of a novel and four known serine protease inhibitors secreted by human glioblastoma cells. J Biochem. 119:334-339. https://doi.org/10.1093/oxfordjournals.jbchem.a021244
  20. Lai JY, Borson ND, Strausbauch MA, Pittelkow MR. 2004. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes. Biochem Biophys Res Commun. 316:407-410. https://doi.org/10.1016/j.bbrc.2004.02.065
  21. Lee SH, Choi BD, Jeong SJ, Jang HS, Kim BO, Lim DS, Park JC, Wang GL, Jeong MJ. 2006. Increased protein of the secretory leukocyte protease inhibitor (SLPI) and the expression of growth factors in NIH3T3 cells by LPS stimulation. Kor J Electron Micros. 36:165-172.
  22. Lee TK, Poon RT, Man K, Guan XY, Ma S, Liu XB, Myers JN, Yuen AP. 2007. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett. 254:308-315. https://doi.org/10.1016/j.canlet.2007.03.017
  23. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Inves. 96:456-464. https://doi.org/10.1172/JCI118056
  24. Morita M, Arakawa H, Nishimura S. 1999. Identification and cloning of a novel isoform of mouse secretory leukocyte protease inhibitor, mSLPI-beta, overexpressed in murine leukemias and a highly liver metastatic tumor, IMC-HA1 cells. Adv Enzyme Regul. 39:341-355. https://doi.org/10.1016/S0065-2571(98)00020-X
  25. Nicolini G, Miloso M, Moroni MC, Beguinot L, Scotto L. 1996. Post-transcriptional control regulates transforming growth factor alpha in the human carcinoma KB cell line. J Biol Chem. 271:30290-30296. https://doi.org/10.1074/jbc.271.47.30290
  26. Perdue RE Jr. 1982. KB cell culture I. Role in discovery of antitumor agents from higher plants. J Nat Prod. 45:418-426. https://doi.org/10.1021/np50022a010
  27. Sallenave JM. 2002. Antimicrobial activity of antiproteinases. Biochem Soc Trans. 30:111-115. https://doi.org/10.1042/bst0300111
  28. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR,Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S. 2004. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 130:295-302. https://doi.org/10.1001/archotol.130.3.295
  29. Shigemasa K, Tanimoto H, Underwood LJ, Parmley TH, Arihiro K, Ohama K, O'Brien TJ. 2001. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors. Int J Gynecol Cancer. 11:454-461. https://doi.org/10.1046/j.1525-1438.2001.01062.x
  30. Shimoya K, Zhang Q, Temma K, Kimura T, Tsujie T, Tsutsui T, Wasada K, Kanzaki T, Koyama M, Murata Y. 2006. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women. Maturitas. 54:141-148. https://doi.org/10.1016/j.maturitas.2004.02.019
  31. Shugars DC, Wahl SM. 1998. The role of the oral environment in HIV-1 transmission. J Am Dent Assoc. 129:851-858. https://doi.org/10.14219/jada.archive.1998.0349
  32. Spiro RH, Alfonso AE, Farr HW, Strong EW. 1974. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg. 128:562-567. https://doi.org/10.1016/0002-9610(74)90276-1
  33. Takes RP, Baatenburg De Jong RJ, Alles MJ, Meeuwis CA, Marres HA, Knegt PP, De La Riviere GB, De Wilde PC, Mooi WJ, Hermans J, Van Krieken JH. 2002. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg. 128:512-518. https://doi.org/10.1001/archotol.128.5.512
  34. Thompson RC, Ohlsson K. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA. 83:6692-6696. https://doi.org/10.1073/pnas.83.18.6692
  35. Twentyman PR, Fox NE, Rees JK. 1989. Chemosensitivity testing of fresh leukraemia cell using the MTT colorimetric assay. Br J Haematol. 71:19-24. https://doi.org/10.1111/j.1365-2141.1989.tb06268.x
  36. Velarde MC, Parisek SI, Eason RR, Simmen FA, Simmen RCM. 2005. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells. J Endocrinol. 184:141-151. https://doi.org/10.1677/joe.1.05800
  37. Westin U, Nystrom M, Ljungcrantz I, Eriksson B, Ohlsson K. 2002. The presence of elafin, SLPI, IL1-RA and STNF alpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm. 11:7-12. https://doi.org/10.1080/09629350210304
  38. Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA. 2002. Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growthassociated genes. J Biol Chem. 277:29999-30009. https://doi.org/10.1074/jbc.M203503200

피인용 문헌

  1. Secretory leukocyte protease inhibitor promotes differentiation and mineralization of MC3T3-E1 preosteoblasts on a titanium surface vol.14, pp.2, 2011, https://doi.org/10.3892/mmr.2016.5381
  2. Secretory leukocyte protease inhibitor reduces inflammation and alveolar bone resorption in LPS-induced periodontitis in rats and in MC3T3-E1 preosteoblasts vol.20, pp.6, 2011, https://doi.org/10.1080/19768354.2016.1250817
  3. Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration vol.59, pp.2, 2017, https://doi.org/10.2334/josnusd.16-0534
  4. Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma vol.40, pp.4, 2011, https://doi.org/10.4103/ijmpo.ijmpo_75_18